Zeo ScientifiX, Inc. (ZEOX) Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company specializing in developing biological therapeutics aimed at treating degenerative diseases and fostering regenerative medicine. Its flagship investigational product, Zofin, is an acellular biologic therapy sourced from perinatal materials. This candidate is currently in Phase I/II clinical trials, evaluating its efficacy for COVID-19, chronic obstructive pulmonary disease (COPD), and knee osteoarthritis. The company's portfolio also includes Patient Pure X, an autologous, blood-derived biologic technology designed to enhance the body's natural capacity to reduce cellular inflammation and promote tissue healing. Furthermore, Zeo ScientifiX develops and distributes products containing its proprietary ingredients for topical aesthetic applications. These offerings include ZEO GROW X, a professional-grade formula delivering concentrated topical exosomes to support follicular function, as well as ZEO GROW BOOST and EXO FOLLICLE FUEL. Founded in 2011, the company was formerly known as Organicell Regenerative Medicine, Inc. before rebranding to Zeo ScientifiX, Inc. in February 2024. It is headquartered in Davie, Florida.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Zeo ScientifiX, Inc. OTC:ZEOX Healthcare · Biotechnology
Mkt Cap $10.66M
Vol 0
$ Vol 0
RVOL 0
Earnings 0
Press Release ● Major ⚠ 4
Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine
ZEO ScientifiX signed a definitive strategic agreement with Pluri to build a combined U.S. manufacturing and commercialization platform for regenerative medicine, aesthetics, wellness, and longevity.
In exchange for rights to Pluri's manufacturing technology, ZEO will issue shares representing 50% of its outstanding common stock at closing, and Pluri will gain exclusive U.S. rights to the Cellav aesthetics line through ZEO's physician network.
Closing is expected in Q4 2026 and does not require stockholder approval from either company; ZEO's results are expected to be consolidated into Pluri's financials post-closing.
For ZEO holders the deal is a double-edged event: it brings Pluri's clinical development and cell-manufacturing capabilities in-house, but cuts existing holders' ownership in half.
• 6d ago AI analysis › Press Release ⚠ 4
ZEO ScientifiX Plans Expansion into Georgia and Tennessee as New Regenerative Medicine Laws Take Effect
ZEO ScientifiX plans to expand its regenerative medicine operations into Georgia and Tennessee following each state's enactment of new laws establishing frameworks for physician-performed stem cell and regenerative therapies.
Georgia House Bill 1275 was signed May 11, 2026, and Tennessee House Bill 2246 on May 19, 2026; the company intends to support providers with regenerative biologics, physician education, and product documentation, building on its Florida footprint under that state's 2025 law.
The company itself cautions that the state laws do not constitute FDA approval and that providers remain responsible for compliance with federal law, licensing rules, and standards of care.
No financial terms, investment amounts, or revenue expectations were disclosed; CEO Ian Bothwell framed the move as building a scalable national platform as additional states adopt similar frameworks.
• 1mo ago AI analysis › Press Release
ZEO ScientifiX Announces Multidisciplinary Expert Faculty Lineup for the ZEO Xperience
ZEO ScientifiX announced the multidisciplinary faculty lineup for the inaugural ZEO Xperience, a regenerative medicine conference taking place October 23-25 in Fort Lauderdale.
The event features a hands-on training session led by specialists including Drs. Stacy Chimento, Michael Magee, and Joseph Banno, covering applications ranging from aesthetics to orthopedics.
CEO Ian Bothwell noted that the conference is designed to bridge the gap between scientific innovation and clinical practice by integrating regulatory, manufacturing, and clinical education.
• 2mo ago AI analysis › Press Release
ZEO ScientifiX Launches First-of-Its-Kind ZEO Xperience, a Three-Day Immersive Regenerative Medicine Experience for Healthcare Professionals
ZEO ScientifiX announced the launch of ZEO Xperience, a three-day immersive educational event tailored for healthcare professionals in the regenerative medicine field.
Scheduled for October 23-25 in Fort Lauderdale, the event focuses on biologics education, hands-on clinical training, and practice growth strategies.
CEO Ian Bothwell emphasized that the initiative aims to move beyond traditional lectures to provide practical implementation strategies for clinicians.
• 2mo ago AI analysis › Press Release
ZEO ScientifiX Strengthens South Florida's Growing Biotechnology Ecosystem Through Regenerative Medicine Innovation
ZEO ScientifiX is operating from Nova Southeastern University's Center for Collaborative Research to strengthen its role in the South Florida biotechnology ecosystem.
The company is focusing on advancing regenerative medicine by increasing investment in physician education initiatives, including Master Classes and webinars.
Management believes the region's growing life sciences sector provides a strong foundation for the company's long-term growth and scientific collaborations.
• 3mo ago AI analysis › Press Release
ZEO ScientifiX Reports Strong Revenue Growth for Three Months and Six Months Ended April 30, 2026
ZEO ScientifiX reported Q1 revenue of $2.58 million, up 124.6% year-over-year, driven by strong demand for its allogenic biologic products in Florida.
Six-month revenue grew 79.9% to $4.03 million while gross margins held steady at 80%, helping reduce the net loss to $1.0 million from $2.6 million in the prior-year period.
CEO Ian Bothwell cited the results as an important inflection point, noting increased physician adoption and broader awareness of the company's regenerative technologies.
• 3mo ago AI analysis › Press Release
ZEO ScientifiX to Host Live Educational Webinar for Healthcare Professionals Exploring the Southeast Regenerative Medicine Revolution
ZEO ScientifiX announced it will host a live educational webinar titled "One Year Later, Three States Stronger: The Southeast Regen Revolution" on July 22, 2026.
The event will analyze Florida's first year of stem cell legislation and discuss recent adoptions in Tennessee and Georgia.
Panelists include leadership from research, medical, and regulatory divisions, focusing on physician education as regenerative medicine expands in the Southeast.
• 4mo ago AI analysis › Press Release
ZEO ScientifiX Donates Products to Support Pediatric Burn Reconstruction Mission in Peru
ZEO ScientifiX donated regenerative biologics products to support a humanitarian mission in Cusco, Peru, providing reconstructive care to children with severe burn injuries.
The 10-day mission, supported by Medical Advisory Board member Dr. Constantino Mendieta, evaluated approximately 80 children and performed nearly 40 reconstructive surgeries.
General Manager Sean Vega-Stanton emphasized the donation aligns with the company's commitment to expanding access to advanced therapeutic options.
• 4mo ago AI analysis › Press Release
ZEO ScientifiX Expands Medical Advisory Board with Leaders in Regenerative and Longevity Medicine
ZEO ScientifiX announced the addition of nine physicians and scientific innovators to its Medical Advisory Board, expanding its network in regenerative and longevity medicine.
The new members include specialists in orthopedics, oncology, pain management, and longevity science, such as Elizabeth Parrish of BioViva Sciences and Dr. Mark A. Rosenberg.
The board serves as a scientific body for clinical protocol research and physician education, rather than a direct revenue-generating unit. The company also noted its status as a $101 million semi-finalist in the XPRIZE Healthspan competition.
• 4mo ago AI analysis › Press Release
ZEO ScientifiX Launches Physician-Led Patient Masterclass Program Following Grassroots Demand in the Southeast
ZEO ScientifiX launched its Physician-Led Patient Masterclass program, formalizing a grassroots model that emerged from high demand in Vero Beach, Florida.
The initiative aims to help physicians educate their patients on regenerative medicine, addressing safety concerns and product quality variability in the expanding market.
The company has already trained over 600 physicians in the Southeast in the past year, creating a network ready to scale this patient-education framework.
• 5mo ago AI analysis › Press Release
ZEO ScientifiX Announces That Unaudited Monthly Sales Surpassed $1.0 million in April 2026, the First Time The Company Has Achieved This Milestone.
accessnewswire.com • 5mo ago Press Release
ZEO ScientifiX Surpasses 500 Physicians Trained in Regenerative Medicine Compliance; Monthly Masterclasses Average 70+ Clinicians
accessnewswire.com • 6mo ago Press Release ● Critical
Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics - Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX (OTCQB:ZEOX)
accessnewswire.com • 6mo ago Press Release
ZEO ScientifiX (OTCQB: ZEOX) Selected as Qualified Team Advancing into the XPRIZE Healthspan Semi-Finals Stage
accessnewswire.com • 6mo ago 
